X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3402) 3402
Conference Proceeding (484) 484
Book Review (215) 215
Publication (177) 177
Book Chapter (53) 53
Magazine Article (53) 53
Dissertation (28) 28
Book / eBook (6) 6
Government Document (6) 6
Paper (4) 4
Journal / eJournal (3) 3
Trade Publication Article (2) 2
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gips (1996) 1996
index medicus (1147) 1147
gypsum (1030) 1030
gip (922) 922
humans (661) 661
animals (546) 546
analysis (510) 510
male (482) 482
endocrinology & metabolism (462) 462
materials science, multidisciplinary (462) 462
glucose (448) 448
glucagon-like peptide-1 (441) 441
glp-1 (437) 437
construction & building technology (400) 400
insulin (395) 395
gastric-inhibitory polypeptide (383) 383
glucagon (334) 334
female (297) 297
druckfestigkeit (286) 286
secretion (270) 270
zement (267) 267
diabetes (262) 262
insulin - metabolism (252) 252
adult (250) 250
insulin secretion (249) 249
mice (247) 247
engineering, civil (240) 240
obesity (235) 235
insulin - blood (228) 228
type 2 diabetes (228) 228
cement (215) 215
engineering, chemical (213) 213
blood glucose - metabolism (208) 208
gastric inhibitory polypeptide - metabolism (207) 207
middle aged (202) 202
dextrose (199) 199
environmental sciences (199) 199
hydration (196) 196
incretin (196) 196
hydratation (190) 190
glucagon-like peptide 1 (187) 187
mineral (187) 187
dependent insulinotropic polypeptide (186) 186
portlandzement (186) 186
rats (186) 186
concrete (185) 185
gastric inhibitory polypeptide - blood (185) 185
mechanical properties (178) 178
ettringit (177) 177
glucose-dependent insulinotropic polypeptide (176) 176
flugasche (167) 167
peptides (162) 162
gastric inhibitory polypeptide - pharmacology (157) 157
sulfat (155) 155
biochemistry & molecular biology (154) 154
energy & fuels (151) 151
hormones (146) 146
gastric inhibitory polypeptide (140) 140
engineering, environmental (138) 138
calcium (134) 134
calciumsulfat (132) 132
komposit (132) 132
diabetes mellitus, type 2 - drug therapy (131) 131
physiology (130) 130
sulfates (130) 130
kalkstein (129) 129
ettringite (128) 128
hormones, hormone substitutes, and hormone antagonists (128) 128
research (126) 126
röntgendiffraktion (123) 123
minerals (121) 121
glucose tolerance test (120) 120
endocrine system (118) 118
materials science (118) 118
pharmacology & pharmacy (118) 118
polypeptides (118) 118
cements (116) 116
diabetes mellitus (116) 116
behavior (115) 115
mikrostruktur (115) 115
rauchgasentschwefelung (115) 115
glucose metabolism (114) 114
abridged index medicus (111) 111
calcit (111) 111
kinetics (110) 110
strength (110) 110
caso4 (109) 109
microstructure (109) 109
building materials (108) 108
metabolism (106) 106
compressive strength (105) 105
gip protein (104) 104
insulin resistance (103) 103
additiv (101) 101
physiological aspects (101) 101
diabetes mellitus, type 2 - metabolism (100) 100
fly-ash (100) 100
performance (100) 100
glucagon-like peptide 1 - metabolism (99) 99
calcium-sulfate (97) 97
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3480) 3480
German (17) 17
Japanese (14) 14
French (12) 12
Spanish (9) 9
Swedish (9) 9
Chinese (8) 8
Korean (7) 7
Croatian (6) 6
Polish (6) 6
Portuguese (6) 6
Turkish (5) 5
Czech (3) 3
Italian (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical and Biophysical Research Communications, ISSN 0006-291X, 02/2018, Volume 496, Issue 3, pp. 898 - 903
Glucagon-like peptide 1 (GLP-1), an incretin gastrointestinal hormone, is secreted when stimulated by nutrients including metabolizable sugars such as glucose... 
Allulose | GLP-1 | GIP
Journal Article
Development of new incretin drugs: promising therapies, 12/2006
New agents are being added to the armamentarium of drugs used for the treatment of diabetes mellitus. Today, extensive research is being conducted on incretin... 
Diabetes mellitus, GLP-1, GIP, DPP-IV
Journal
Endocrine Journal, ISSN 0918-8959, 2017
Canagliflozin has a robust inhibitory effect on sodium glucose transporter (SGLT)-2 and a mild inhibitory effect on SGLT1. The main purpose of this study was... 
GLP-1 | Canagliflozin | SGLT1 | GIP
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 11/2018, Volume 239, Issue 2, pp. 215 - 227
Glucose-dependent insulinotropic polypeptide (GIP) has been recognized in the last decade as an important contributor of bone remodelling and is necessary for... 
GIP-Tag | Bone matrix composition | Bone loss | Bone microarchitecture | GIP | QUALITY | DRUG-DELIVERY | GUIDELINES | STRENGTH | HYDROXYAPATITE | bone loss | OSTEOPOROSIS | bone matrix composition | DELIVERY-SYSTEM | MINERAL DENSITY | DENSITY DISTRIBUTION | ENDOCRINOLOGY & METABOLISM | GIP(1-30) | DEPENDENT INSULINOTROPIC POLYPEPTIDE | bone microarchitecture
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 06/2018, Volume 828, pp. 31 - 41
Huntington's disease (HD) is an inherited complex progressive neurodegenerative disorder with an established etiopathology linked to neuronal oxidative stress... 
D-Ala2GIP | Redox | (Pro3)GIP | Quinolinic acid | Huntington's disease | Pro | D-Ala | GIP | Index Medicus
Journal Article
Life Sciences, ISSN 0024-3205, 12/1999, Volume 66, Issue 2, pp. 91 - 103
Journal Article
Diabetologia, ISSN 0012-186X, 7/2007, Volume 50, Issue 7, pp. 1532 - 1540
Journal Article
06/2011
Mechanisms to augment the cellular function and mass of beta-cells may be effective means of treating type 2 diabetes. Important in the physiological control... 
GLP-1 | beta-cell | 0564 | incretin | 0719 | diabetes | GIP
Dissertation
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 10/2017, Volume 19, Issue 10, pp. 1436 - 1445
Aims: To investigate the pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of RG7697, a dual glucose-dependent insulinotropic... 
RG7697, RO6811135 | NNC | 0090‐2746 | dual | pharmacodynamics | safety | 1 agonist | pharmacokinetics | type 2 diabetes mellitus | GLP | GIP | NNC0090-2746 | dual GIP/GLP-1 agonist | ACTIVATION | RO6811135 | RECEPTOR AGONISTS | QTC INTERVAL | RESPONSES | GLUCAGON-LIKE PEPTIDE-1 | BIOLOGY | ENDOCRINOLOGY & METABOLISM | SECRETION | GASTRIC-INHIBITORY POLYPEPTIDE | RG7697 | ASSOCIATION | Gastric Inhibitory Polypeptide - agonists | Hypoglycemic Agents - pharmacokinetics | Double-Blind Method | Humans | Middle Aged | Drugs, Investigational - pharmacokinetics | Male | Diabetes Mellitus, Type 2 - metabolism | Blood Glucose - drug effects | Dose-Response Relationship, Drug | Hypoglycemic Agents - administration & dosage | Glucagon-Like Peptide 1 - agonists | Drugs, Investigational - administration & dosage | Adult | Female | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Complications and side effects | Safety and security measures | Peptides | Low density lipoproteins | Glycosylated hemoglobin | Glucose | Dextrose | Appetite | Pharmacodynamics | Fasting | Polypeptides | Glucagon | Diabetes mellitus | Body weight | Diarrhea | Gastric emptying | Nausea | GIP protein | Hypoglycemia | Insulin | Immunological tolerance | Hemoglobin | Diabetes | Pharmacokinetics | Glucagon-like peptide 1 | Index Medicus
Journal Article
DIABETES, ISSN 0012-1797, 05/2019, Volume 68, Issue 5, pp. 906 - 917
The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are secreted postprandially and contribute... 
ENERGY-EXPENDITURE | GLP-1 | ANTAGONIST | FOOD-INTAKE | Y GASTRIC BYPASS | ENDOCRINOLOGY & METABOLISM | POSTPRANDIAL GLUCOSE | INHIBITORY POLYPEPTIDE | SECRETION | GIP RECEPTOR | INCRETIN | Glucose tolerance | Polypeptides | Intravenous administration | Glucagon | Peptides | Secretion | Gastric emptying | GIP protein | Glucose | Hormones | Insulin | Glucagon-like peptide 1
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 07/2019, Volume 20, Issue 14, p. 3532
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are important regulators of metabolism, making their receptors (GLP-1R... 
GLP-1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | INCRETINS | arrestin | CHEMISTRY, MULTIDISCIPLINARY | GIP | receptor | PHARMACOLOGY | PEPTIDE-1 | glucagon | GASTRIC-INHIBITORY POLYPEPTIDE | GIP RECEPTOR | BINDING
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 06/2018, Volume 314, Issue 6, pp. E572 - E583
Journal Article
Zement-Kalk-Gips, ISSN 0341-0560, 1976
Journal
Journal of Physics: Conference Series, ISSN 1742-6588, 08/2017, Volume 884, p. 12043
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 2015, Volume 308, Issue 5, pp. E414 - E425
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 10/2017, Volume 19, Issue 10, pp. 1446 - 1453
Journal Article